Advocacy Center

CONGRESSIONAL TESTIMONY

Each year, AAI submits written testimony to the House and Senate subcommittees that fund NIH. Among other things, these testimonies include an NIH funding request and highlight important immunologic discoveries.

  • AAI submits testimony to the Senate in support of a $44.7 billion budget for NIH for FY 2021 (05/21/20)
  • AAI submits testimony to the House in support of a $44.7 billion budget for NIH for FY 2021 (03/20/20)

LETTERS AND COMMENTS

The AAI Committee on Public Affairs communicates the policy positions of AAI through letters to legislators, government officials/agencies, and other organizations that have an impact on biomedical research.

  • AAI joins coalition letter to the NIH Human Fetal Tissue Ethics Advisory Board (07/28/20)
  • AAI signs community letter urging the Trump Administration to reverse its decision to bypass CDC in collecting and reporting COVID-19 patient data (07/17/20)
  • AAI signs community letter in support of scientific and public health experts, like Dr. Anthony Fauci (07/15/20)
  • AAI sends message to AAI members expressing support for scientific and public health leaders like Dr. Anthony Fauci, and encouraging them to offer support to these leaders via social media (07/14/20)
  • AAI signs community letter strongly opposing new Trump Administration policy that will effectively deport international students who are enrolled at U.S. universities that are providing classes exclusively online, or who are taking only online classes. (07/08/20)
  • AAI sends letter to Senate Health, Education, Labor and Pensions Chairman Lamar Alexander in response to his White Paper on “Preparing for the Next Pandemic” (06/26/20)
  • AAI issues statement opposing U.S. withdrawal from the WHO and visa changes affecting Chinese scientists/students (06/09/20)
  • AAI submits testimony to the Senate in support of a $44.7 billion budget for NIH for FY 2021 (05/21/20)
  • AAI sends letter to NIH Director Collins regarding the termination of a research grant (05/20/20)
  • AAI endorses bipartisan Senate effort to provide funding for pandemic-related research losses, including additional support for trainees (4/29/20 and 05/08/20)
  • AAI endorses bipartisan House effort to provide funding for pandemic-related research losses, including additional support for trainees (4/28/20)
  • AAI sends letter urging the President, Congressional leaders, to heed advice of Dr. Fauci and other scientific and public health experts during COVID-19 pandemic (04/15/20)
  • AAI signs community letters to House and Senate appropriators calling for a nonpartisan review of the COVID-19 response (03/30/20)
  • AAI signs community letter to President Trump urging him to lift restrictions on federally funded human fetal tissue research, particularly for research on COVID-19 (03/25/20)
  • AAI submits testimony to the House in support of a $44.7 billion budget for NIH for FY 2021 (03/20/20)
  • AAI issues statement strongly opposing President Trump’s FY 2021 budget request for NIH (02/10/20)
  • AAI submits comments to NIH on its draft policy on data management and sharing (01/07/20)
  • AAI issues statement on the alleged HHS word ban (12/19/17)
  • AAI submits letter to members of the tax reform bill Conference Committee strongly opposing elimination of the tuition waiver tax exemption for graduate students (12/08/17)
  • AAI submits letter to key House leaders strongly opposing elimination of the tuition waiver tax exemption for graduate students (11/13/17)
  • AAI submits letter to NIH regarding its proposed Grant Support Index (05/31/17)
  • AAI provides written testimony to the Senate Labor-HHS Appropriations Subcommittee on FY 2018 funding for NIH (05/25/17)
  • AAI signs multi-organization letter to congressional leaders urging them to reject President Trump’s proposed cuts to science (05/24/17)
  • AAI issues statement opposing President Trump’s proposed FY 2018 NIH budget cut (03/24/17)
  • AAI provides written testimony to the House Labor-HHS Appropriations Subcommittee on FY 2018 funding for NIH (3/6/17)
  • AAI joins community letter to President Trump supporting vaccine safety (02/07/17)
  • AAI President Arlene Sharpe releases message to members on issues of national concern (02/01/17)
  • AAI signs multi-society letter on White House Executive Order on immigration and visas (01/31/17)
2016 Letters and Comments
  • AAI submits comments to NIH regarding the use of interim research products (12/6/16)
  • AAI sends letter to Representatives Upton and DeGette regarding the 21st Century Cures Act (11/29/16)
  • AAI provides written testimony to the House Labor-HHS Appropriations Subcommittee on FY 2017 funding for NIH (4/11/16)
  • AAI provides written testimony to the Senate Labor-HHS Appropriations Subcommittee on FY 2017 funding for NIH (4/11/16)
  • AAI submits comments to NSABB regarding its draft recommendations for gain-of-function research studies (3/08/16)
2015 Letters and Comments
  • AAI submits letter to Senator Cassidy expressing concern about efforts to legislate the re-allocation of funding within the NIH portfolio (12/4/15)
  • AAI submits comments on simplifying NIH grant application instructions (9/22/15)
  • AAI comments on proposed changes to the Animal Welfare Act Regulations (8/21/15)
  • AAI submits comments to NIH on its framework for a strategic plan (8/14/15)
  • AAI responds to APHIS Notice of Petition on defining alternatives in animal research (5/28/15)
  • AAI submits comments to USDA request for information on reducing regulatory burdens (5/18/15)
  • AAI responds to NIH Request for Information on optimizing funding policies to improve the impact and sustainability of biomedical research (5/15/15)
  • AAI letter to Senator Durbin endorsing the American Cures Act (3/9/15)
  • AAI letter to Senator Mikulski endorsing the Accelerating Biomedical Research Act (3/9/15)
  • AAI letter to Representatives DeLauro and Higgins endorsing the Accelerating Biomedical Research Act (3/9/15)
  • AAI issues statement in strong support of routine and seasonal vaccinations (3/6/15)
  • AAI submits comments to NIH on a proposed Emeritus Award for senior investigators (3/6/15)
2014 Letters and Comments
  • AAI responds to NIH Request for Information on reagent-related barriers to reproducibility (12/19/14)
  • AAI letter to NIH regarding the BRAIN Initiative (10/15/14)
  • AAI letter to Representatives DeLauro and Higgins endorsing the Accelerating Biomedical Research Act (9/23/14)
  • AAI letter to Representatives Smith and Bass on the Ebola epidemic (9/15/14)
  • AAI letter to Senators Harkin, Alexander, and Moran, on the Ebola epidemic (9/12/14)
  • AAI statement on the Ebola epidemic (9/12/2014)
  • AAI letter to Senator Harkin endorsing the Accelerating Biomedical Research Act (8/4/2014)
  • AAI letter to Senators Carper and Coburn in opposition to the Conference Accountability Act (7/29/14)
  • AAI letter to the NIH Office of Laboratory Animal Welfare in response to its Proposed Guidance Regarding Significant Changes to Ongoing Animal Activities (5/12/14)
  • AAI letter to Senator Durbin endorsing the American Cures Act (3/10/14)
  • AAI submits testimony to the Senate Committee on Homeland Security and Governmental Affairs regarding federal spending on conference and travel (for the hearing record of 01/14/14)

ADVOCACY RESOURCES

Interested in communicating the value of immunology and biomedical research to policymakers?  These resources will help you do just that. 

  • Sign up for e-action alerts to receive email notifications about key issues and step-by-step instructions on how to make your voice heard
  • Locate and contact your Congressional Representatives
  • State and District NIH factsheets
  • Best Practices for advocating and visiting your Members of Congress
  • How to advocate on social media
  • Federal Funding Report
  • Handout: “The Value of Federally Funded Biomedical & Biological Research”
  • Factsheet: “Animal Research Saves Lives”
  • Factsheet: “Humanized Mouse Models: Using Human Cells to Conquer Disease”

VISIT CAPITOL HILL WITH AAI

AAI is happy to take AAI members to Capitol Hill to advocate for NIH and biomedical research.  If you are going to be in the Washington, D.C., area, contact us to let us know that you are interested in meeting with your Congressional delegation.

Step 1: Contact Manager of Science Policy and Legislative Affairs Jake Schumacher (jschumacher@aai.org) and let him know that you would like to go to Capitol Hill and the dates you are available. (AAI will be in touch with you to schedule a mutually agreeable date)

Step 2: AAI will contact your Congressional delegation and schedule your meetings.

Step 3: AAI will put together everything you need for a successful Hill visit, including talking points and items to hand out to the offices you visit.

Step 4: AAI Director of Public Policy and Government Affairs Lauren Gross will escort you to your appointments and help guide you through your meetings.

It’s that simple!

WORKING WITH FASEB

AAI works both independently and closely with the Federation of American Societies For Experimental Biology (FASEB) to advance biomedical research, immunology, and the interests of AAI members.

AAI is a founding member of FASEB. FASEB has 28 member societies and represents more than 130,000 researchers.

AAI Representative to the FASEB Board (2019 – 2020)

  • Beth A. Garvy, Ph.D., Professor and Chair, Department of Microbiology, Immunology, and Molecular Genetics, University of Kentucky College of Medicine

AAI Members Serving on FASEB Board Standing Committees and Subcommittees (2019 – 2020)

AAI CAPITOL HILL PHOTO GALLERY

Photo-4
Photo-5
Photo-6
Photo-7
Photo-8
Photo-9

© The American Association of Immunologists, Inc.
1451 Rockville Pike, Suite 650, Rockville, Maryland 20852
Phone: (301) 634-7178 | Fax: (301) 634-7887